Additionally, each of these interventions imparts their own set of risks, including musculoskeletal pain with G‐CSF, thromboembolic events with ESAs, and infections, immunological deregulation, and transfusion‐related reactions with use of blood products.10, 46, 47, 48. Here, CSF3 is linked to infection.